Diphtheria，tetanus and acellular pertussis combined Vaccine，adsorbed (Walvax Biotechnology Co Ltd)

吸附无细胞百白破联合疫苗（沃森生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiphtheria，tetanus and acellular pertussis combined Vaccine，adsorbed (Walvax Biotechnology Co Ltd)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTetanusDiphtheriaWhooping Cough

Global Approved IndicationsTetanusDiphtheriaWhooping Cough

Approved Indications in ChinaTetanusDiphtheriaWhooping Cough

Original Approved Country/TerritoryMainland China

Original Approved Date2015/07/27

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesYuxi Walvax Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesYuxi Walvax Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsTetanusDiphtheriaWhooping Cough

Inactive IndicationsN/A

Other Information

ATC CodeJ07AJ52